BANF2
gene geneOn this page
Also known as dJ803K15.1BAF-LBAFLBAF2
Summary
BANF2 (BANF family member 2, HGNC:16172) is a protein-coding gene on chromosome 20p12.1, encoding Barrier-to-autointegration factor-like protein (Q9H503). May play a role in BANF1 regulation and influence tissue-specific roles of BANF1.
Enables identical protein binding activity. Predicted to be involved in chromosome organization. Located in nucleus.
Source: NCBI Gene 140836 — RefSeq curated summary.
At a glance
- GWAS associations: 14
- Clinical variants (ClinVar): 13 total — 2 pathogenic
- MANE Select transcript:
NM_178477
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16172 |
| Approved symbol | BANF2 |
| Name | BANF family member 2 |
| Location | 20p12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ803K15.1, BAF-L, BAFL, BAF2 |
| Ensembl gene | ENSG00000125888 |
| Ensembl biotype | protein_coding |
| Entrez | 140836 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000246090, ENST00000377805, ENST00000427254, ENST00000467330, ENST00000545418
RefSeq mRNA: 3 — MANE Select: NM_178477
NM_001014977, NM_001159495, NM_178477
CCDS: CCDS13129, CCDS54449
Canonical transcript exons
ENST00000246090 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001359811 | 17722716 | 17722878 |
| ENSE00001409887 | 17699966 | 17700055 |
| ENSE00001819187 | 17735665 | 17735871 |
| ENSE00003800248 | 17725023 | 17725151 |
Expression profiles
Bgee: expression breadth ubiquitous, 108 present calls, max score 95.88.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1443 / max 130.8146, expressed in 3 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 183662 | 0.1160 | 3 |
| 183661 | 0.0150 | 3 |
| 183663 | 0.0133 | 3 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 95.88 | gold quality |
| right testis | UBERON:0004534 | 95.48 | gold quality |
| sperm | CL:0000019 | 94.72 | gold quality |
| testis | UBERON:0000473 | 92.48 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.18 | silver quality |
| adult organism | UBERON:0007023 | 77.40 | gold quality |
| body of pancreas | UBERON:0001150 | 74.29 | gold quality |
| kidney epithelium | UBERON:0004819 | 65.28 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 64.78 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 64.40 | gold quality |
| ileal mucosa | UBERON:0000331 | 63.48 | silver quality |
| myocardium | UBERON:0002349 | 63.03 | gold quality |
| tibialis anterior | UBERON:0001385 | 62.83 | silver quality |
| pancreas | UBERON:0001264 | 60.80 | gold quality |
| pancreatic ductal cell | CL:0002079 | 59.06 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 56.89 | gold quality |
| deltoid | UBERON:0001476 | 56.58 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 54.54 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| quadriceps femoris | UBERON:0001377 | 51.52 | gold quality |
| vastus lateralis | UBERON:0001379 | 49.53 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 48.73 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| apex of heart | UBERON:0002098 | 46.42 | gold quality |
| skin of hip | UBERON:0001554 | 45.20 | silver quality |
| thyroid gland | UBERON:0002046 | 44.86 | gold quality |
| muscle tissue | UBERON:0002385 | 44.55 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 44.30 | gold quality |
| ventral tegmental area | UBERON:0002691 | 44.30 | gold quality |
| amniotic fluid | UBERON:0000173 | 44.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.70 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- BAF and BAF-L might contribute to the shaping of the spermatozoon nucleus and, after fertilisation, its transition to the male pronucleus. (PMID:28684548)
- BAF-L Modulates Histone-to-Protamine Transition during Spermiogenesis. (PMID:35216101)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Banf2 | ENSMUSG00000037307 |
| rattus_norvegicus | Banf2 | ENSRNOG00000006032 |
Paralogs (1): BANF1 (ENSG00000175334)
Protein
Protein identifiers
Barrier-to-autointegration factor-like protein — Q9H503 (reviewed: Q9H503)
Alternative names: Barrier-to-autointegration factor 2
All UniProt accessions (3): Q9H503, A0A140VK85, B1AM15
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in BANF1 regulation and influence tissue-specific roles of BANF1.
Subunit / interactions. Homodimer. Heterodimerizes with BANF1.
Subcellular location. Nucleus. Cytoplasm.
Tissue specificity. Expressed strongly in testis and pancreas. Also detected in brain, colon, liver, lung, ovary, placenta, prostate, small intestine, spleen and thymus. Not detected in heart, kidney and skeletal muscle.
Similarity. Belongs to the BAF family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9H503-1 | 1 | yes |
| Q9H503-2 | 2 |
RefSeq proteins (3): NP_001014977, NP_001152967, NP_848572* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004122 | BAF_prot | Family |
| IPR036617 | BAF_sf | Homologous_superfamily |
| IPR051387 | BAF | Family |
Pfam: PF02961
UniProt features (4 total): sequence variant 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H503-F1 | 95.99 | 0.96 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 22 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN, GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GOBP_CHROMOSOME_ORGANIZATION, TAL1ALPHAE47_01, TAL1BETAE47_01, WGTTNNNNNAAA_UNKNOWN, TAL1BETAITF2_01, MYC_UP.V1_DN, ZNF184_TARGET_GENES, GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP, GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN, DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS, FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_NEGATIVE, ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP, GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP
GO Biological Process (1): chromosome organization (GO:0051276)
GO Molecular Function (3): DNA binding (GO:0003677), identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (3): condensed chromosome (GO:0000793), nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle organization | 1 |
| nucleic acid binding | 1 |
| protein binding | 1 |
| binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
933 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| BANF2 | EMD | P50402 | 996 |
| BANF2 | LEMD3 | Q9Y2U8 | 957 |
| BANF2 | LEMD2 | Q8NC56 | 848 |
| BANF2 | H3-3A | P06351 | 831 |
| BANF2 | H3C14 | Q71DI3 | 831 |
| BANF2 | H3-5 | Q6NXT2 | 831 |
| BANF2 | H3C1 | P02295 | 831 |
| BANF2 | H3-4 | Q16695 | 831 |
| BANF2 | H3-7 | Q5TEC6 | 831 |
| BANF2 | LBR | Q14739 | 821 |
| BANF2 | LMNA | P02545 | 811 |
| BANF2 | TMPO | P08918 | 808 |
| BANF2 | LMNB1 | P20700 | 782 |
| BANF2 | VRK1 | Q99986 | 742 |
| BANF2 | PSIP1 | O75475 | 695 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| BANF2 | APAF1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (23): BANF2 (Two-hybrid), BANF2 (Two-hybrid), BANF2 (Two-hybrid), BANF2 (Two-hybrid), CFP (Two-hybrid), PSMA1 (Two-hybrid), MTUS2 (Two-hybrid), ADAMTSL4 (Two-hybrid), DDIT4L (Two-hybrid), WDYHV1 (Two-hybrid), DUSP23 (Two-hybrid), BEND7 (Two-hybrid), BANF1 (Two-hybrid), INCA1 (Two-hybrid), TCF4 (Two-hybrid)
ESM2 similar proteins: A1KXW8, A3KMX7, A4IIA7, A6QL50, A8MYZ0, E1BGQ2, F4I933, F4IVI0, H0Y354, O14772, O35099, O81916, Q08326, Q0VCL9, Q149N8, Q1JQA1, Q29RL0, Q32PE7, Q3T1H6, Q3TTL0, Q4R9C4, Q5F4A1, Q5I0G3, Q5R6Y2, Q5RBW0, Q5RFG8, Q5RJY2, Q5TYM5, Q5U515, Q66J91, Q6DCD7, Q6L9T8, Q6P338, Q7L622, Q866F4, Q86X60, Q8BFZ8, Q8BKW4, Q8BX13, Q8CEL2
Diamond homologs: A8XAC6, O54962, O75531, P61283, Q03565, Q32PE7, Q5HZM3, Q5RBU9, Q66KV4, Q6NTS2, Q6P026, Q8BVR0, Q9H503, Q9R1T1, Q9VLU0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
13 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2427149 | NC_000020.10:g.(?17587682)(18168103_?)del | Pathogenic |
| 625735 | GRCh37/hg19 20p12.2-11.23(chr20:11716825-19331055) | Pathogenic |
SpliceAI
731 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:17725012:T:A | acceptor_gain | 1.0000 |
| 20:17725015:T:A | acceptor_gain | 1.0000 |
| 20:17725153:T:A | donor_loss | 1.0000 |
| 20:17710877:GGC:G | donor_gain | 0.9900 |
| 20:17725010:A:AG | acceptor_gain | 0.9900 |
| 20:17725010:ACT:A | acceptor_gain | 0.9900 |
| 20:17725011:C:G | acceptor_gain | 0.9900 |
| 20:17725020:CAGG:C | acceptor_gain | 0.9900 |
| 20:17725021:A:AG | acceptor_gain | 0.9900 |
| 20:17725021:A:G | acceptor_loss | 0.9900 |
| 20:17725021:AG:A | acceptor_gain | 0.9900 |
| 20:17725021:AGGA:A | acceptor_gain | 0.9900 |
| 20:17725022:G:GG | acceptor_gain | 0.9900 |
| 20:17725022:G:GT | acceptor_loss | 0.9900 |
| 20:17725022:GG:G | acceptor_gain | 0.9900 |
| 20:17725022:GGA:G | acceptor_gain | 0.9900 |
| 20:17725022:GGAG:G | acceptor_gain | 0.9900 |
| 20:17734371:G:GG | donor_gain | 0.9900 |
| 20:17734382:G:GT | donor_gain | 0.9900 |
| 20:17735661:CCAG:C | acceptor_loss | 0.9900 |
| 20:17735662:CA:C | acceptor_loss | 0.9900 |
| 20:17735663:A:AC | acceptor_loss | 0.9900 |
| 20:17735663:A:AG | acceptor_gain | 0.9900 |
| 20:17735664:G:GA | acceptor_loss | 0.9900 |
| 20:17735664:G:GG | acceptor_gain | 0.9900 |
| 20:17700052:CCTGG:C | donor_loss | 0.9800 |
| 20:17700054:TGG:T | donor_loss | 0.9800 |
| 20:17700055:GGTGA:G | donor_loss | 0.9800 |
| 20:17700056:GTGAG:G | donor_loss | 0.9800 |
| 20:17700057:T:A | donor_loss | 0.9800 |
AlphaMissense
600 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:17735686:T:C | F50L | 0.982 |
| 20:17735688:C:A | F50L | 0.982 |
| 20:17735688:C:G | F50L | 0.982 |
| 20:17735716:T:C | F60L | 0.971 |
| 20:17735718:T:A | F60L | 0.971 |
| 20:17735718:T:G | F60L | 0.971 |
| 20:17735803:T:C | F89L | 0.970 |
| 20:17735805:C:A | F89L | 0.970 |
| 20:17735805:C:G | F89L | 0.970 |
| 20:17735761:G:C | A75P | 0.961 |
| 20:17735687:T:C | F50S | 0.960 |
| 20:17735717:T:C | F60S | 0.959 |
| 20:17735791:T:A | W85R | 0.959 |
| 20:17735791:T:C | W85R | 0.959 |
| 20:17725056:T:C | F11L | 0.950 |
| 20:17725058:C:A | F11L | 0.950 |
| 20:17725058:C:G | F11L | 0.950 |
| 20:17735783:T:C | L82P | 0.939 |
| 20:17735793:G:C | W85C | 0.939 |
| 20:17735793:G:T | W85C | 0.939 |
| 20:17725082:G:C | K19N | 0.936 |
| 20:17725082:G:T | K19N | 0.936 |
| 20:17735729:T:C | L64P | 0.936 |
| 20:17725057:T:C | F11S | 0.931 |
| 20:17735675:T:A | L46Q | 0.931 |
| 20:17735675:T:G | L46R | 0.931 |
| 20:17735703:G:C | K55N | 0.931 |
| 20:17735703:G:T | K55N | 0.931 |
| 20:17725129:T:C | L35S | 0.930 |
| 20:17735681:G:A | G48E | 0.927 |
dbSNP variants (sampled 300 via entrez): RS1000073854 (20:17716334 T>C), RS1000164618 (20:17692663 C>A,G,T), RS1000232907 (20:17695025 A>T), RS1000328598 (20:17723356 C>T), RS1000418175 (20:17704133 G>A,C), RS1000447702 (20:17700916 G>A,T), RS1000448562 (20:17721367 AT>A), RS1000509363 (20:17707166 G>A), RS1000565312 (20:17721027 T>C), RS1000677286 (20:17726658 C>A), RS1000822035 (20:17719194 G>A), RS1000873284 (20:17702544 A>T), RS1000896298 (20:17724797 C>G,T), RS1000993220 (20:17730545 G>A), RS1001027846 (20:17714871 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
14 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST006979_536 | Heel bone mineral density | 2.000000e-10 |
| GCST008077_84 | LDL cholesterol levels | 1.000000e-06 |
| GCST008078_119 | LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 8.000000e-11 |
| GCST008078_15 | LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | 9.000000e-13 |
| GCST008079_109 | LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 3.000000e-85 |
| GCST008079_38 | LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | 7.000000e-77 |
| GCST008086_42 | LDL cholesterol levels in current drinkers | 1.000000e-09 |
| GCST008086_61 | LDL cholesterol levels in current drinkers | 2.000000e-10 |
| GCST009365_36 | LDL cholesterol levels x short total sleep time interaction (2df test) | 4.000000e-08 |
| GCST010243_94 | Apolipoprotein B levels | 3.000000e-10 |
| GCST010245_101 | LDL cholesterol levels | 3.000000e-08 |
| GCST010396_166 | Gut microbiota (bacterial taxa, hurdle binary method) | 2.000000e-06 |
| GCST011347_62 | Low density lipoprotein cholesterol levels | 9.000000e-11 |
| GCST012490_11 | Femur bone mineral density x serum urate levels interaction | 1.000000e-13 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009270 | heel bone mineral density |
| EFO:0004611 | low density lipoprotein cholesterol measurement |
| EFO:0004329 | alcohol drinking |
| EFO:0004615 | apolipoprotein B measurement |
| EFO:0007874 | gut microbiome measurement |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Pesticides | affects methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.